by Lori Solomon Patients with hemophilia A or B with inhibitors have a lower annualized bleeding rate with concizumab than with no prophylaxis, according to a phase 3 study published online Aug. 31 in the New England Journal of Medicine. Tadashi Matsushita, M.D., Ph.D., from Nagoya University Hospital in Japan, and colleagues evaluated the safety...
By Erin Michael Numerous studies have provided evidence supporting the use of ivermectin to prevent and treat COVID-19, according to the Frontline COVID-19 Critical Care Alliance. Paul Marik, MD, FCCM, FCCP, founder of the alliance and a professor and chief of the division of pulmonary and critical care medicine at Eastern Virginia Medical School, said that...
UNIVERSITY OF WASHINGTON HEALTH SCIENCES/UW MEDICINE IMAGE: PANDEMIC CORONAVIRUS RESEARCHERS DAVID VESSLER (LEFT) AND ALEJANDRA TORTORICI (RIGHT) AT THE UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE IN SEATTLE. THE VEESLER LAB USES CRYO-ELECTRON MICROSCOPY TO STUDY. A mix of ultrapotent antibodies from recovered COVID-19 patients has been shown to recognize and lock down the infection machinery...
